. Substantial contributions to the conception or design of the work; or the acquisition, analysis or interpretation of data for the work; AND . Drafting the work or revising it critically for important intellectual content; AND . Final approval of the version to be published; AND . Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. 1 While these all-inclusive criteria are clear and specific, the implementation of a policy to assure credible authorship is challenging. When more than, say, 10 authors are listed for a single paper it could be questioned what the real contribution of some of these authors has been, whether they can take responsibility for the full content and, in fact, whether they are fully aware of the contents and implications of their work. Apart from the criteria mentioned above, there are several other reasons why those with final responsibility for the submission of a paper choose to invite or accept authors. Perhaps one of the most common reasons for researchers to offer authorship is the role these putative authors have played in collecting data necessary for the research, typically in an international context. It is easy to understand why this happens as authorship is often the 'carrot' held out to entice centres to participate, since it confers credit and has important academic, social, and financial implications. For many clinicians and others involved in data collection in patient care, e.g. investigators providing subsets or biochemical or genetic data or contributing populations of patients to collaborative analyses, there are limited means to acquire authorships other than through their recognition in papers from larger consortia. In a world where scientific reputations are, for better or worse, still largely driven by publication records, it can be understood that these investigators make their contributions conditional on future authorships. Vice-versa, lead investigators will face major problems in getting the data should they not be able to offer these. A paper published in Nature on Drosophila genomics was published with more than 1000 authors. 2 Justification was in part found in the handwork done by 900 graduates to edit highly repetitive DNA sequences. It should be acknowledged that, compared to the number of fruit flies needed for the research, the number of authors was likely quite modest! The above mechanisms are common, difficult to detect or prevent but non-compliant with the ICMJE criteria. Yet, even within the bounds of the legitimate criteria for authorship, papers can still sometimes be 'overcrowded' with authors. Research has become increasingly multidisciplinary and international, and combinations of expertise and competences tend to drive the quality of research results. The involvement of multiple centres and groups leads to more authors qualifying for inclusion. Not only authorship per se, but also the ranking of authors is an issue. Traditionally, the author that writes the paper heads the list, while the last author tends to be the one who takes overall responsibility for the work. Therefore, in many academic assessments the first and last authorships are the ones that bear most weight. Consequently, we now regularly encounter shared first authorships, shared last authorships or other creative combinations.
Indeed, it may be hard to define exactly which of two or more, commonly junior, authors made the largest contribution to the actual writing of a paper. Given these complexities, one may question whether the current system of a simple listing of individual authors is capable of providing appropriate credits to the different roles and responsibilities that researchers may have had in a project leading to scientific publication.
Guideline reports are notorious for their long listings of individual authors. They are also articles of major interest to readers and therefore attract a high number of citations. So, the role of authorship here is a delicate issue. Currently, authorship of guidelines is a blend of the actual work carried out, the 'buy-in' of several stakeholders (i.e. interested parties whose agreement to support them is fundamental, and who have often been involved in their formulation), and the representativeness needed to maximize visibility (i.e. to assure sufficient exposure to the scientific community). For many of the authors, the typical involvement may be limited to reviewing subsequent versions of the report. A problem is that for many busy opinion leaders in medicine, these papers are fast tracks to scientific visibility and citations and certainly 'lower-hanging scientific fruit' than laborious and time-consuming original research. Guidelines are important, but too many guidelines, position papers, consensus reports and similar learned views may not benefit patients and society and confuse rather than confirm. Honouring these scientific products with across-the-board authorships promotes rather than prevents such practices and needs to be carefully reappraised. There are good reasons, in fact, to publish guidelines under the single affiliation of a scientific or professional association or other prestigious and competent institution although, at present, this is uncommon. In our view, journals should collectively decide to have guidelines published on behalf of associations rather than as the work of individual authors. If needed, participants in the preparation of the guidelines and their roles can be listed separately or even in supplementary on-line material.
An available solution to long lists of authors heading a paper is that the paper be written by a writing committee (whose individuals are the listed authors) on behalf of a study group, or even simply 'on behalf of' a study group (the study group itself being the sole author), listing the multiple individual contributors at the end of the paper. This is an attractive alternative but it also has a limitation. While all authors listed in this manner at the end of the paper will find the paper included in their personal publication overview (e.g. in PubMed), individual citations are not counted in Web of Science or other bibliometric systems. This will reduce the attraction of the option to some. Yet it seems like a fair solution in those circumstances where contributions do not fully comply with the criteria for authorship but where there is, nevertheless, a justified need to give credit to work done. For example, this is the case for guideline papers.
Rules on authorship and, more importantly, authorship practices cannot be changed by a single journal in isolation. Should the European Journal of Preventive Cardiology single-mindedly decide to restrict the number of authors, as we have entertained, this may put the Journal at a competitive disadvantage when other journals are prepared to consider papers with an unrestricted number of authors. As this would particularly affect papers that may be well cited, such as guideline reports, international consortia or multi-institution collaborations, and since journals like authors depend on the extent to which their published work is cited, this would harm the position of our Journal.
Something, however, needs to be done. First and foremost, the discussion on authorship should be encouraged among the scientific community and a reappraisal is needed for a system that currently is difficult to comprehend, easy to corrupt and has ceased to provide sufficient credibility to the diversity of roles that individuals and groups play in science. In the meantime, we in the European Journal of Preventive Cardiology have decided not to restrict the number of authors on submissions to the Journal, but to perform a more rigorous assessment of the contribution that each author has made. A written assessment has been introduced as part of the submission process and requires that every author explicitly state their role and contributions to the manuscript. Hopefully, in the future, all scientific journals will move to adopt a common policy on authorship, that will clarify for all concerned an issue that at present remains nebulous.
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